Asia Pacific Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Gastrointestinal Therapeutics Market would witness market growth of 4.7% CAGR during the forecast period (2022-2028).

Gastrointestinal disorders are among the most common complaints made to a primary care physician globally and are also connected with the substantial healthcare and economic burden. However, despite the prominent healthcare and financial burden of GI disorders, many digestive diseases are still under-researched.

In addition, the treatment options are not beneficial enough, leaving the patients dissatisfied with their present treatment. Thus, from a volume/value point of view, the significant area of unmet requirement and room for further development, combined with the large share of the pharmaceutical sector, make the GI therapeutics market an attractive target for therapeutic effect, where the development of new, affordable, and innovative, effective treatments could provide greater patients satisfaction, higher profit returns, and decreased economic burden.

In patients with GORD, one of the largest and fastest growing GI segments, the liquid content of the stomach regurgitates back up into the esophagus, causing ulcerations of the esophagus. The predominant symptom of which is the unpleasant sensation of heartburn, prominently at night. Acid suppressants used in the treatment of GORD include proton pump inhibitors, histamine H2 receptor antagonists, and antacids; however, proton pump inhibitors (PPI) have emerged as the most effective option for treatment.

Disease and illnesses of the gastrointestinal system have increased significantly in the last decade because of the considerable lifestyle changes. People with gastrointestinal illness have a high prevalence of depression, impaired central nervous system functioning, anxiety, and stress. The overall majority of self-reported gastrointestinal problems was 18%, with prominent variations among regions, and it increased with the rising age. Adults from the age group 45-54 and 55-64 years were prominently more prone to have gastrointestinal problems when compared to people below 44 years of age.

The China market dominated the Asia Pacific Gastrointestinal Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,846.3 million by 2028. The Japan market is experiencing a CAGR of 4.1% during (2022 - 2028). Additionally, The India market would display a CAGR of 5.3% during (2022 - 2028).

Based on Type, the market is segmented into Branded and Generics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Route of Administration, the market is segmented into Injectable and Oral & Others. Based on Application, the market is segmented into Crohn's Disease, Ulcerative Colitis, GERD, IBS and Others. Based on Drug Class, the market is segmented into Biologics/Biosimilar, Anti-Diarrheal, Anti-Emetics, Digestive Enzymes, Aminosalicylates, Proton Pump Inhibitors, Laxatives & H2 Antagonists and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Gastrointestinal Therapeutics Market is Projected to reach USD 45.9 Billion by 2028, at a CAGR of 3.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, AbbVie, Inc., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.), Johnson & Johnson (Janssen Global Services, LLC), AstraZeneca PLC, Bayer AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Branded
• Generics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Route of Administration

• Injectable
• Oral & Others

By Application

• Crohn's Disease
• Ulcerative Colitis
• GERD
• IBS
• Others

By Drug Class

• Biologics/Biosimilar
• Anti-Diarrheal
• Anti-Emetics
• Digestive Enzymes
• Aminosalicylates
• Proton Pump Inhibitors
• Laxatives & H2 Antagonists
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• AbbVie, Inc.
• Takeda Pharmaceutical Company Limited
• Pfizer, Inc.
• Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
• Johnson & Johnson (Janssen Global Services, LLC)
• AstraZeneca PLC
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Gastrointestinal Therapeutics Market, by Type
1.4.2 Asia Pacific Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 Asia Pacific Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 Asia Pacific Gastrointestinal Therapeutics Market, by Application
1.4.5 Asia Pacific Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 Asia Pacific Gastrointestinal Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market

Chapter 4. Asia Pacific Gastrointestinal Therapeutics Market by Type
4.1 Asia Pacific Branded Market by Country
4.2 Asia Pacific Generics Market by Country

Chapter 5. Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel
5.1 Asia Pacific Retail Pharmacies Market by Country
5.2 Asia Pacific Hospital Pharmacies Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country

Chapter 6. Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration
6.1 Asia Pacific Injectable Market by Country
6.2 Asia Pacific Oral & Others Market by Country

Chapter 7. Asia Pacific Gastrointestinal Therapeutics Market by Application
7.1 Asia Pacific Crohn's Disease Market by Country
7.2 Asia Pacific Ulcerative Colitis Market by Country
7.3 Asia Pacific GERD Market by Country
7.4 Asia Pacific IBS Market by Country
7.5 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Gastrointestinal Therapeutics Market by Drug Class
8.1 Asia Pacific Biologics/Biosimilar Market by Country
8.2 Asia Pacific Anti-Diarrheal Market by Country
8.3 Asia Pacific Anti-Emetics Market by Country
8.4 Asia Pacific Digestive Enzymes Market by Country
8.5 Asia Pacific Aminosalicylates Market by Country
8.6 Asia Pacific Proton Pump Inhibitors Market by Country
8.7 Asia Pacific Laxatives & H2 Antagonists Market by Country
8.8 Asia Pacific Others Market by Country

Chapter 9. Asia Pacific Gastrointestinal Therapeutics Market by Country
9.1 China Gastrointestinal Therapeutics Market
9.1.1 China Gastrointestinal Therapeutics Market by Type
9.1.2 China Gastrointestinal Therapeutics Market by Distribution Channel
9.1.3 China Gastrointestinal Therapeutics Market by Route of Administration
9.1.4 China Gastrointestinal Therapeutics Market by Application
9.1.5 China Gastrointestinal Therapeutics Market by Drug Class
9.2 Japan Gastrointestinal Therapeutics Market
9.2.1 Japan Gastrointestinal Therapeutics Market by Type
9.2.2 Japan Gastrointestinal Therapeutics Market by Distribution Channel
9.2.3 Japan Gastrointestinal Therapeutics Market by Route of Administration
9.2.4 Japan Gastrointestinal Therapeutics Market by Application
9.2.5 Japan Gastrointestinal Therapeutics Market by Drug Class
9.3 India Gastrointestinal Therapeutics Market
9.3.1 India Gastrointestinal Therapeutics Market by Type
9.3.2 India Gastrointestinal Therapeutics Market by Distribution Channel
9.3.3 India Gastrointestinal Therapeutics Market by Route of Administration
9.3.4 India Gastrointestinal Therapeutics Market by Application
9.3.5 India Gastrointestinal Therapeutics Market by Drug Class
9.4 South Korea Gastrointestinal Therapeutics Market
9.4.1 South Korea Gastrointestinal Therapeutics Market by Type
9.4.2 South Korea Gastrointestinal Therapeutics Market by Distribution Channel
9.4.3 South Korea Gastrointestinal Therapeutics Market by Route of Administration
9.4.4 South Korea Gastrointestinal Therapeutics Market by Application
9.4.5 South Korea Gastrointestinal Therapeutics Market by Drug Class
9.5 Singapore Gastrointestinal Therapeutics Market
9.5.1 Singapore Gastrointestinal Therapeutics Market by Type
9.5.2 Singapore Gastrointestinal Therapeutics Market by Distribution Channel
9.5.3 Singapore Gastrointestinal Therapeutics Market by Route of Administration
9.5.4 Singapore Gastrointestinal Therapeutics Market by Application
9.5.5 Singapore Gastrointestinal Therapeutics Market by Drug Class
9.6 Malaysia Gastrointestinal Therapeutics Market
9.6.1 Malaysia Gastrointestinal Therapeutics Market by Type
9.6.2 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel
9.6.3 Malaysia Gastrointestinal Therapeutics Market by Route of Administration
9.6.4 Malaysia Gastrointestinal Therapeutics Market by Application
9.6.5 Malaysia Gastrointestinal Therapeutics Market by Drug Class
9.7 Rest of Asia Pacific Gastrointestinal Therapeutics Market
9.7.1 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type
9.7.2 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel
9.7.3 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration
9.7.4 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application
9.7.5 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense

TABLE 1 Asia Pacific Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Branded Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Branded Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Generics Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Generics Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Injectable Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Injectable Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific GERD Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific GERD Market by Country, 2022 - 2028, USD Million
TABLE 31 Asia Pacific IBS Market by Country, 2018 - 2021, USD Million
TABLE 32 Asia Pacific IBS Market by Country, 2022 - 2028, USD Million
TABLE 33 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 34 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 35 Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Asia Pacific Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 38 Asia Pacific Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 39 Asia Pacific Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 40 Asia Pacific Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 41 Asia Pacific Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 42 Asia Pacific Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 43 Asia Pacific Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 44 Asia Pacific Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 45 Asia Pacific Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 46 Asia Pacific Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 47 Asia Pacific Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 48 Asia Pacific Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 49 Asia Pacific Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 50 Asia Pacific Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 51 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 52 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 53 Asia Pacific Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 54 Asia Pacific Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 55 China Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 China Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 China Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 China Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 China Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 China Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 China Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 62 China Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 63 China Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 China Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 China Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 66 China Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 67 Japan Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 Japan Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 Japan Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 70 Japan Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 71 Japan Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Japan Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Japan Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Japan Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Japan Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 Japan Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 Japan Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Japan Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 India Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 80 India Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 81 India Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 82 India Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 83 India Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 India Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 India Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 86 India Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 87 India Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 88 India Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 89 India Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 90 India Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 91 South Korea Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 92 South Korea Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 93 South Korea Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 94 South Korea Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 95 South Korea Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 96 South Korea Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 97 South Korea Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 98 South Korea Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 99 South Korea Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 100 South Korea Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 101 South Korea Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 102 South Korea Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 103 Singapore Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 104 Singapore Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 105 Singapore Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 106 Singapore Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 107 Singapore Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 108 Singapore Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 109 Singapore Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 110 Singapore Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 111 Singapore Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 112 Singapore Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 113 Singapore Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 114 Singapore Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 115 Malaysia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 116 Malaysia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 117 Malaysia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 118 Malaysia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 119 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 120 Malaysia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 121 Malaysia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 122 Malaysia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 123 Malaysia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 124 Malaysia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 125 Malaysia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 126 Malaysia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 127 Rest of Asia Pacific Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 128 Rest of Asia Pacific Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 129 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 132 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 133 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 134 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 135 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 136 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 137 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 138 Rest of Asia Pacific Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 139 Key Information – Abbott Laboratories
TABLE 140 Key information – AbbVie, Inc.
TABLE 141 Key Information – Takeda Pharmaceutical Company Limited
TABLE 142 Key Information – Pfizer, Inc.
TABLE 143 key information – Salix Pharmaceuticals, Inc.
TABLE 144 Key information –Johnson & Johnson
TABLE 145 KEY INFORMATION – AstraZeneca PLC
TABLE 146 Key Information – Bayer AG
TABLE 147 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 148 Key Information – Cipla Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Recent strategies and developments: Takeda Pharmaceutical Company Limited